Literature DB >> 2869737

Effects of nipradilol (K-351) on alpha-adrenoceptor mediated responses in various isolated tissues.

A Ohira, Y Wada, M Fujii, M Nakamura, Y Kasuya, Y Hamada, K Shigenobu.   

Abstract

Nipradilol competitively antagonized norepinephrine- or phenylephrine-induced contractile responses of guinea-pig thoracic aorta. These actions of nipradilol were about 6 times less potent than those of phentolamine. Nitroglycerin showed a non-competitive antagonistic action on norepinephrine-induced contractions of aorta. Furthermore, nipradilol competitively inhibited norepinephrine-induced contractions of rat vas deferens and dose-dependently reduced the phenylephrine-induced inhibitory responses in rabbit ileum. These antagonistic actions of nipradilol were 30 to 100 times less potent than those of phentolamine. Nitroglycerin did not appreciably affect these alpha-adrenoceptor mediated responses in rat vas deferens and rabbit ileum. The inhibitory action of clonidine on the twitch contraction of rat vas deferens produced by intramural stimulation was only slightly antagonized by nipradilol (pA2 = 5.4). Nipradilol and nitroglycerin showed a non-competitive antagonistic action on clonidine-induced contractions of canine saphenous vein after the exposure to phenoxybenzamine, while phentolamine competitively inhibited the clonidine responses. These results suggest that nipradilol possesses an alpha 1-adrenoceptor blocking action; it possesses very weak or practically no presynaptic alpha 2-blocking activity but shows a non-competitive antagonistic action on postsynaptic alpha 2-adrenoceptor mediated contractile responses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2869737

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  6 in total

1.  Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans.

Authors:  M Kanno; M Araie; H Koibuchi; K Masuda
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

2.  Visual field loss in patients with normal-tension glaucoma under topical nipradilol or timolol: subgroup and subfield analyses of the nipradilol-timolol study.

Authors:  Makoto Araie; Shiroaki Shirato; Yoshio Yamazaki; Yoshiaki Kitazawa; Yasuo Ohashi
Journal:  Jpn J Ophthalmol       Date:  2010-08-11       Impact factor: 2.447

3.  Nitric oxide mediated venodilator effects of nebivolol.

Authors:  A J Bowman; C P Chen; G A Ford
Journal:  Br J Clin Pharmacol       Date:  1994-09       Impact factor: 4.335

4.  Clinical efficacy of topical nipradilol and timolol on visual field performance in normal-tension glaucoma: a multicenter, randomized, double-masked comparative study.

Authors:  Makoto Araie; Shiroaki Shirato; Yoshio Yamazaki; Yoshiaki Kitazawa; Yasuo Ohashi
Journal:  Jpn J Ophthalmol       Date:  2008-09-05       Impact factor: 2.447

5.  Effect of five years of treatment with nipradilol eye drops in patients with normal tension glaucoma.

Authors:  Kenji Inoue; Kei Noguchi; Masato Wakakura; Goji Tomita
Journal:  Clin Ophthalmol       Date:  2011-08-26

6.  Retrobulbar hemodynamic effects of nipradilol in normal and normal-tension glaucoma eyes.

Authors:  Mitsushi Fukukita; Masashi Ido; Syunsuke Osawa; Mikio Sasoh; Motoyasu Furuta; Kunio Ito; Masahiko Sugimoto; Yukitaka Uji
Journal:  J Ophthalmol       Date:  2011-11-03       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.